| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |